Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (00874.HK) Stock Price, Financials & Summary | drillr

Skip to content

Sign in Sign up

Price chart

Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.1x

Market Cap

HKD 21.96B

MomentumView details →

1D Return

+0.97%

YTD Return

−23.76%

RSI (14)

23.7

ValuationView details →

P/E (Fwd)

—

EV/EBITDA

4.1x

Market Cap

HKD 21.96B

RSI (14)

23.7

MomentumView details →

1D Return

+0.97%

YTD Return

−23.76%

ProfitabilityView details →

Gross Margin

15.28%

Net Margin

3.31%

EBITDA Margin

4.75%

ROE (TTM)

6.56%

ROA (TTM)

2.92%

Asset Turnover

0.88x

GrowthView details →

Revenue YoY

+2.38%

EPS YoY

−8.72%

FCF YoY

+917.45%

Revenue CAGR 3Y

+3.13%

EPS CAGR 3Y

−9.14%

EBITDA YoY

−4.86%

EarningsView details →

EPS (Actual)

HKD 0.22

EPS Surprise

—

Beats (12Q)

—

Next Q EPS Est

—

Avg Surprise (4Q)

—

Rev Surprise

—

Capital & dividendView details →

Debt/Equity

0.50x

Current Ratio

0.20x

Quick Ratio

0.20x

Div Yield

6.39%

Div Rate

HKD 0.86

Div Growth 1Y

−1.50%

Financials snapshotView financials →

Revenue (TTM)

77.59B

Net Income (TTM)

2.57B

Op. CF (TTM)

3.43B

Next earningsOct 27, 2026 →

Latest newsMore news →

Singapore biotech company LionTCR will work with Guangzhou Pharmaceutical Holdings to develop and accelerate the clinical translation of TCR-T cell therapies.9d ago

Baiyunshan and other parties jointly established Hongyang Health Technology (Yangzhou) Co., Ltd., a health technology company in Yangzhou, China, with Li Jin as legal representative, covering cosmetics production and daily necessities sales.11d ago

Similar companies

天士力600535.SH 济川药业600566.SH Aprogen Biologics Inc.003060.KS 哈药股份600664.SH 华海药业600521.SH 皓元医药688131.SH Find similar companies →

Latest newsMore news →

Singapore biotech company LionTCR will work with Guangzhou Pharmaceutical Holdings to develop and accelerate the clinical translation of TCR-T cell therapies.9d ago Baiyunshan and other parties jointly established Hongyang Health Technology (Yangzhou) Co., Ltd., a health technology company in Yangzhou, China, with Li Jin as legal representative, covering cosmetics production and daily necessities sales.11d ago Guangzhou Baiyunshan Hejigong Pharmaceutical Co., Ltd., a subsidiary of Guangzhou Pharmaceutical Holdings Limited, acquired a controlling stake in Beijing Fama Star Pharmaceutical Technology Co., Ltd. for 330 million yuan.39d ago